Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
08/04/2011 | US20110189241 Process For Controlling The Particle Size of A [3-(Trifluoromethyl)Phenyl]-1-Aminopropane Derivative |
08/04/2011 | US20110189240 Microencapsulated compositions for endoluminal tissue engineering |
08/04/2011 | US20110189220 Mushroom compositions and methods for making and using |
08/04/2011 | US20110189207 Methods for soluble zalpha11 cytokine receptors |
08/04/2011 | US20110189189 Combination of cd137 antibody and ctla-4 antibody for the treatment of proliferative diseases |
08/04/2011 | US20110189188 Novel gp96 derived peptides |
08/04/2011 | US20110189176 Methods of treating diseases with dll4 antagonists |
08/04/2011 | US20110189152 Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
08/04/2011 | US20110189149 New Uses of Lactic Acid Bacteria and Bifidobacteria |
08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
08/04/2011 | US20110189134 Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same |
08/04/2011 | US20110189107 Alpha-amylase inhibitors: the montbretins and uses thereof |
08/04/2011 | DE102009041241A1 New heteroaromatic compounds are hypoxia-inducible factor inhibitors useful to treat and/or prevent e.g. cancer or tumor diseases, heart attack, arrhythmia, stroke, psoriasis, diabetic retinopathy, rheumatoid arthritis and polycythemia |
08/04/2011 | CA2787615A1 Methods of treating diabetes with dll4 antagonists |
08/04/2011 | CA2786621A1 Methods of treating glucose metabolism disorders |
08/03/2011 | EP2351776A1 Oxyntomodulin analogues and their effects on feeding behaviour |
08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
08/03/2011 | EP2351756A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
08/03/2011 | EP2351751A1 Substituted pyrazolopyrimidines |
08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
08/03/2011 | EP2351744A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase |
08/03/2011 | EP2351743A1 Bicyclic compound |
08/03/2011 | EP2351568A2 Uses of dpp-iv inhibitors |
08/03/2011 | EP2351567A2 Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients |
08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
08/03/2011 | EP2351564A1 Methods of treating an inflammatory-related disease |
08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
08/03/2011 | EP2351562A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
08/03/2011 | EP2351561A2 Novel methods and compositions for alleviating pain |
08/03/2011 | EP2351559A2 Novel use of panduratin derivative or boesenbergia pandurata extract |
08/03/2011 | EP2351558A1 Therapeutic agent for tympanites in ruminant animal |
08/03/2011 | EP2351493A1 Composition based on conjugated linoleic acid for canned products comprising at least one tuna |
08/03/2011 | EP2351491A1 Concentrated liquid diet |
08/03/2011 | EP2350311A1 Diacylglycerol acyltransferase inhibitors |
08/03/2011 | EP2350280A1 Immunosuppression compound and treatment method |
08/03/2011 | EP2350097A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
08/03/2011 | EP2350068A2 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
08/03/2011 | EP2350067A2 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
08/03/2011 | EP2350060A2 Melanocortin receptor agonists |
08/03/2011 | EP2350054A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
08/03/2011 | EP2350053A2 Soluble mtor complexes and modulators thereof |
08/03/2011 | EP2350029A1 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors |
08/03/2011 | EP2350022A1 New benzimidazole derivatives |
08/03/2011 | EP2350016A2 Aryl gpr120 receptor agonists and uses thereof |
08/03/2011 | EP2350003A1 Substituted disulfonamides as bri-modulators |
08/03/2011 | EP2349484A2 Heteroaryl derivatives as dgat1 inhibitors |
08/03/2011 | EP2349326A2 A new pharmaceutical product |
08/03/2011 | EP2349322A1 Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities |
08/03/2011 | EP2349304A1 Uses of curculigo latifolia (c. latifolia) extracts |
08/03/2011 | EP2349281A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
08/03/2011 | EP2349280A1 Methods of treatment of hyperuricemia and associated disease states |
08/03/2011 | EP2349266A1 Sulfonamide containing compounds and uses thereof |
08/03/2011 | EP2349264A1 Pyrimidinium derivatives for use in the treatment or prevention of diabetes |
08/03/2011 | EP2349261A2 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
08/03/2011 | EP2349240A1 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug |
08/03/2011 | EP2348885A1 Biscuit comprising guar gum |
08/03/2011 | EP2348868A1 Novel mitochondrial uncoupling methods and compositions for enhancing adipocyte thermogenesis |
08/03/2011 | EP2348846A1 Disubstituted azepan orexin receptor antagonists |
08/03/2011 | EP2183222B1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
08/03/2011 | EP2120980B1 An anti-diabetic extract of rooibos |
08/03/2011 | EP1934198B1 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
08/03/2011 | EP1446104B2 Spray drying methods |
08/03/2011 | EP1212055B1 Neurotherapeutic composition comprising a beta-lactam compound |
08/03/2011 | CN1875002B Phenyl derivatives as PPAR agonists |
08/03/2011 | CN1859917B Medicine and food/beverage for ameliorating hyperglycemia |
08/03/2011 | CN102143965A Pyrazolopyrimidines and their use for the treatment of CNS disorders |
08/03/2011 | CN102143956A Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
08/03/2011 | CN102143747A New pyridine derivatives as leptin receptor modulator mimetics |
08/03/2011 | CN102143744A Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof |
08/03/2011 | CN102143743A Reducing cholesterol levels with combined use of querceting and statin |
08/03/2011 | CN102140126A Rotundic acid derivative and synthesis method thereof as well as application of rotundic acid derivative in preparing medicament for preventing and curing cardiovascular disease |
08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
08/03/2011 | CN102139115A Preparation method for atorvastatin cyclodextrin inclusion compound and oral solid preparation thereof |
08/03/2011 | CN102139110A Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
08/03/2011 | CN102139076A Traditional Chinese medicine for treating diabetic foot |
08/03/2011 | CN102139075A Traditional Chinese medicine for treating diabetic acral necrosis |
08/03/2011 | CN102139066A Chinese medicinalal soft capsule |
08/03/2011 | CN102139065A Capsule prepared from Chinese herbal medicines for treating cardiovascular and cerebrovascular diseases |
08/03/2011 | CN102139061A Traditional Chinese medicine for treating diabetic constipation |
08/03/2011 | CN102139057A Healthcare tea capable of lowering glucose |
08/03/2011 | CN102139055A Traditional Chinese medicine for treating diabetic gastroplegia |
08/03/2011 | CN102139054A Traditional Chinese medicine for treating diabetic retinopathy |
08/03/2011 | CN102139049A Traditional Chinese medicine for treating diabetic skin pruritus |
08/03/2011 | CN102139044A Traditional Chinese medicine for treating diabetic coronary heart disease |
08/03/2011 | CN102139043A Traditional Chinese medicine for treating diabetic retinopathy |
08/03/2011 | CN102139036A Traditional Chinese medicine for treating diabetic gout |
08/03/2011 | CN102139023A Health-care tobacco-control type Chinese medicinal herb sucking product and preparation method |
08/03/2011 | CN102139018A Chinese medicinal weight-reducing tea |
08/03/2011 | CN102139014A Traditional Chinese medicine for treating diabetic nephropathy |
08/03/2011 | CN102139002A Cortex phellodendri polysaccharide extract and preparation method and medical application thereof |
08/03/2011 | CN102138974A Traditional Chinese medicine for treating diabetic cardiopathy |
08/03/2011 | CN102138969A Traditional Chinese medicine for treating diabetic diarrhea |
08/03/2011 | CN102138968A Soft capsule containing natto and gingko |
08/03/2011 | CN102138962A Tamarindus pericap extract, and preparation method and application thereof |
08/03/2011 | CN102138958A Process for extracting and purifying flavonoids in grosvener siraitia plants |
08/03/2011 | CN102138948A Medicament for treating hyperlipidemia and coronary sclerosis and preparation method thereof |
08/03/2011 | CN102138947A Propolis Chinese medicinal composition |